Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Tumor Immunity
100%
DNA Methyltransferase 3B (DNMT3B)
100%
PTPN11
100%
SPARC
100%
Head-to-head Comparison
100%
CCN4
100%
Flow Cytometry
25%
Human Data
25%
Clinical Correlation
25%
Immunosuppression
25%
Immune-mediated
25%
Knockout Cell Lines
25%
Proteomics
12%
Knock
12%
Tumor
12%
Tumor Growth
12%
Improved Survival
12%
Reduced Survival
12%
Survival Benefit
12%
Tumor Cells
12%
Gene Products
12%
Cancer Cells
12%
Immune Infiltration
12%
C57BL
12%
Natural Killer Cells
12%
Primary Melanoma
12%
Tumor Growth Rate
12%
Melanocytes
12%
Tumor Microenvironment
12%
Kinetic Analysis
12%
Melanoma Patients
12%
Parameter Estimation
12%
Immunodeficient Mice
12%
Immunocompromised Host
12%
Melanocytic Tumor
12%
Cell Infiltration
12%
Cell Manufacturing
12%
Functional Assay
12%
Syngeneic Mice
12%
Secreted Factors
12%
Cell-intrinsic
12%
Novel Immunotherapy
12%
Mouse Melanoma Model
12%
Monte Carlo Analysis
12%
Markov Chain Monte Carlo
12%
Immunotherapy Targets
12%
Markov Chain Monte Carlo Approach
12%
Intrinsic Rate of Increase
12%
Cas9 Protein
12%
Biochemistry, Genetics and Molecular Biology
Tumor Progression
100%
Flow Cytometry
100%
Tumor Immunity
100%
DNMT3A
100%
PTPN11
100%
Osteonectin
100%
Proteomics
50%
Cancer Cell
50%
Syngenic
50%
Gene Product
50%
Mediator
50%
Natural Killer Cell
50%
C57BL 6 Mouse
50%
Melanocyte
50%
Cell Infiltration
50%
CRISPR/Cas9
50%
Immune Infiltration
50%
Immunology and Microbiology
Immunotherapy
100%
Tumor Immunity
100%
Immunosuppression
66%
Cell Line
33%
Cancer Cell
33%
Tumor Cell
33%
Mediator
33%
Gene Product
33%
Syngenic
33%
Immunocompromised Patient
33%
Cell Infiltration
33%
Immune Cell Infiltration
33%
Proteomics
33%
Natural Killer Cell
33%
Melanocyte
33%
C57BL 6 Mouse
33%
CRISPR/Cas9
33%